Zhong Ji LS Group Limited announced unaudited interim results for the six months ended June 30, 2024, showing a 41.8% increase in revenue to HKD 42.4 million, a 25.6% increase in gross profit to HKD 33.3 million, but a 85.9% decrease in profit before tax to HKD 0.7 million. Net assets slightly increased to HKD 432.1 million, and no interim dividend was recommended. The company's main businesses include LS science business, lending and financial consulting business, securities and other investments, and property investment. During the period, LS science business generated revenue of approximately HKD 25.18 million, while lending and financial consulting business generated revenue of HKD 17.22 million. The company's shares are listed on The Stock Exchange of Hong Kong Limited and have strengthened the development of LS science business during the period, including establishing a strategic partnership with Thermo Fisher Scientific (Hong Kong) Limited. There were no significant events after the reporting period.

Zhong Ji LS Group Limited announced unaudited interim results for the six months ended June 30, 2024, showing a 41.8% increase in revenue to HKD 42.4 million, a 25.6% increase in gross profit to HKD 33.3 million, but a 85.9% decrease in profit before tax to HKD 0.7 million. Net assets slightly increased to HKD 432.1 million, and no interim dividend was recommended. The company's main businesses include LS science business, lending and financial consulting business, securities and other investments, and property investment. During the period, LS science business generated revenue of approximately HKD 25.18 million, while lending and financial consulting business generated revenue of HKD 17.22 million. The company's shares are listed on The Stock Exchange of Hong Kong Limited and have strengthened the development of LS science business during the period, including establishing a strategic partnership with Thermo Fisher Scientific (Hong Kong) Limited. There were no significant events after the reporting period.